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though NK cells and T cells share a number of biolog- 
ical functions including cytotoxicity and lymphokine 
secretion (1), they appear to differ fundamentally in the struc- 
ture of their antigen receptors. Whereas T  cells are known 
to recognize foreign antigens via their CD3-associated het- 
erodimeric ce/15 or 3'/g TCK, the antigen recognition struc- 
tures used by NK cells are still in the process of being duci- 
dated. In this respect, current evidence (2-5) suggests that 
NK cells express polymorphic (but nonrearranging) receptors 
that bdoug to the NKR-Pl and Ly-49 families in mouse and 
the recently doned p58 family in humans. The nature of the 
ligands recognized by NK cells is controversial, although there 
is functional evidence that both Ly-49 and p58 receptor fam- 
ilies may mediate negative signals upon engagement of par- 
ticular  MHC  class  I  alleles  (2-5).  In  contrast,  NKK-Pl 
receptors appear to bind to a heterogeneous group of carbo- 
hydrate ligands (6), thereby triggering effector functions such 
as cytolysis (6,  7). 
NK and T  cells probably arise from related but distinct 
developmental lineages (8). Whereas the majority of ce//3 or 
~///~ T cells depend upon the thymus for their development, 
NK cells develop normally in athymic (nude) mice. Further- 
more, recombination-deficient mutant (RAG-/-  or SCID) 
mice have normal levels of NK cells despite the complete ab- 
sence of ce/B or "y//~ T  cells. Nevertheless, it is likely that 
both NK and T cells arise from a common "lymphoid com- 
mitted" precursor cell, since both lineages (as weU as B cells) 
are absent in mice lacking the ikaros transcription factor, 
whereas other hematopoietic cells develop normally in these 
mutant mice (9). 
In view of the apparently distinct ligands recognized by 
NK cells and T cells, it is of considerable interest that a subset 
oflymphocytes sharing receptor structures common to both 
lineages has been identified in mice (10-12),  rats (13),  and 
humans (14, 15). In the mouse, the best-defined such popu- 
lation coexpresses the ce/B TCR and NKI.1 (16) (a member 
of the NKR-Pl  family), although other subsets of mouse 
TCR-cx/fl cells expressing members of the Ly-49 family have 
been described (17,  18).  This  commentary will  focus on 
NKI.1 + TCK-odfl + (hereafter referred to as NK1 + T) cells 
and, in particular, will summarize recent insights into their 
origin, specificity,  and function. 
Phenotype and TCR Expression of NKI + T  Cells 
The surface phenotype of NK1 + T  cells is dramatically 
different from that of normal ce/fl T  cells. As summarized 
in Table 1, NK1 + T cells express a number of markers usu- 
ally associated with an activation/memory phenotype (but 
absent from naive T  cells) such as CD44 ugh, CD45RB I~ 
and CD62L  l~  In addition, NK1 + T cells express the IL-2R 
B chain (CD122), which is normally present on conventional 
NK cells but not T cells. Whereas most mature r  T cells 
express either CD4 or CD8 coreceptors, NK1 + T  cells are 
almost exclusively either CD4 + or CD4-8-. 
Another unique feature of NK1 + T  cells relates to their 
TCK expression. In comparison with normal r  T  cells, 
NK1 + T cells express approximately threefold lower surface 
density of TCR-cx/fl and have often been referred to in the 
literature as TCK  "intermediate" (TCR  int) cells.  Further- 
more, the TCR.usage of NK1 + T cells is heavily biased for 
both c~ and fl chains. Thus, most NK1 + T cells use one of 
only three Vfl domains (Vf18.2,  Vfl7, or Vfl2) (19),  and a 
single Vex domain (Vcd4) is highly overrepresented among 
NK1 + T  cells but rarely used by conventional r  T  cells 
(20).  The latter finding explains the earlier puzzling obser- 
vations of Taniguchi and co-workers (21), who identified a 
subset of peripheral T  cells expressing an invariant Vol14- 
Jc~281 rearrangement with no junctional diversity. 
Relationship of NKI + T Cells to TCR int, Invariant VcrI4, and 
Ipr/eld T  Cells 
An important (but not yet totally resolved) issue is the 
relationship of NK1 § T  cells to other unusual TCK-ot//~ 
subsets.  As noted above,  both TCK  i~t and invariant Votl4 
T  cell subsets have been described. Although all NK1 + T 
cells are clearly of a TCR  ~  phenotype, it has not been pos- 
sible technically to address whether other (NKI.1-) subsets 
of TCR.  int cells exist. In this issue of the journal, Sato et al. 
(22) provide a partial solution to this problem. By taking 
advantage of the expression of IL-2RB on all TCR  i"~ (but 
not conventional TCKhig  h) cells,  these authors  show that 
NKI.1 defines only a subset of the TCR  ~t population. Fur- 
ther  analysis  of  CD4/8  phenotype  indicates  that  most 
NKI.1 +  TCR  i~t  cells  are  CD4 +  or  CD4-8-,  whereas 
NKI.1-  TCR  i~t cells are mainly CD8 + . It should be noted 
that the CD8 + TCR  int subset, while resembling NK1 + T 
cells in terms of surface phenotype, has not yet been defined 
in terms of TCR usage or function. 
The precise relationship between NK1 + T  cells and in- 
variant Vo114 cells has been more difficult to ascertain be- 
cause of the absence of  reliable antibodies against Vcd4. Using 
semiquantitative  PCR,  Lantz  and Bendelac (20)  recently 
demonstrated  a  marked  enrichment  of  Vex14 +  cells  in 
CD44~s  h CD4 + thymocytes (corresponding to the CD4 + 
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Volume 182  September 1995  633-638 Table  1.  Phenotype  and TCR Repertoire of NK1 + T  Cells, Conventional T  Cells, and Ipr/gld T  Cells 
Marker  NK1 + T  Naive T  Memory T  Ipr/gld T 
NKI.1  +  -  _  _ 
CD4/8  CD4 § or  CD4 + or  CD4 § or  CD4-8- 
CD4- 8-  CD8 §  CD8 § 
B220  -  -  _  + 
CD44 (Pgp-1)  High  Low  High  High 
CD45RB  Low  High  Low  High 
CD62L (Mel 14)  Low  High  Low  +/- 
CD24 (HSA)  Low  Low  Low  + / - 
CD122 (IL2-R3)  High  Low  Low  Low 
TCR-CD3  Intermediate  High  High  Intermediate 
TCR V3  2,  7,  8.2  All  All  All 
TCR Vc~  14  All  All  All 
Clonal deletion 
(endogenous superantigen)  No  Yes  Yes  Yes 
subset of thymic NK1 + T  cells),  and most T  cell hybrids 
derived by fusion of this population to the BW5147 thymoma 
used the invariant Voe14-Jc~281 rearrangement. Thus, it ap- 
pears likely that most NK1 + T  cells (but few conventional 
T cells) use Vo~14; however, it is not known whether other 
TCR  int subsets  (such as the CD8 + TCR  in~ population de- 
scribed  above)  are likewise enriched in Vc~14  + cells. 
Mice homozygous for the Ipr or gld mutations (which are 
defective in functional Fas or Fas ligand, respectively) develop 
autoimmune syndromes accompanied by peripheral expan- 
sion of a unique subset of CD4-8-  TCR-cff3 cells (23). 
These Ipr/gld T cells resemble NK1 + T cells in that they are 
TCR  i"t  and  express  certain  activation  markers  such  as 
CD44hish; however,  they differ phenotypically from NK1 + 
T cells in that they express the B cell marker B220 and fail 
to express NKI.1 (Table 1). Furthermore, lpr/gld T cells and 
NK1 + T cells differ fundamentally in their TCR repertoires 
(Table  1).  Whereas NK1 + T  cells use a highly restricted 
subset of V3 and Va chains, Ipr/gldT cells have a much more 
diverse relx~toire (although V38 is somewhat ~ented). 
Moreover, Ipr and gld T cells are subjected to deletional toler- 
ance in the presence of endogenous mouse mammary tumor 
virus superantigens, whereas NK1 + T  cells in general are 
not. Hence, it appears that Ipr/gld T  cells are not related to 
the NK1 + T  lineage. 
Developmental  Origin of NK1 + T  Cells 
The developmental origin of NK1 § T cells is controver- 
sial. Historically, a T  cell subset corresponding phenotypi- 
cally to NK1 + T  cells was first identified among CD4-8- 
thymocytes (24, 25), although it was not appreciated for some 
time that these cells actually express NKI.1 (11). Subsequently, 
NK1 + T ceils were observed in other lymphoid organs such 
as spleen (10) and bone marrow (12) as well as in liver (26). 
NK1 + T  cells resident in the thymus appear  to develop  in 
situ, since cells of the NKI.1 + TCR-ot/3 + phenotype can 
be generated in fetal thymus organ cultures established from 
14-d mouse embryos (27).  Furthermore, neonatal thymus 
grafts implanted in congenitally athymic (nude) mice can give 
rise  to small numbers of NK1 + T  cells in recipient bone 
marrow and  spleen  (28),  suggesting a  thymus-dependent 
origin for at least some peripheral NK1 + T cells. Neverthe- 
less, NKI.1 + TCR-al3 + cells are readily detectable in ex- 
trathymic tissues such as bone marrow (12), spleen (29), and 
liver (30) of nude mice. Thus, it appears that NK1 + T cells 
can be of either thymus-dependent or -independent origin. 
This conclusion is compatible with the finding that NK1 + 
T cells require expression of an endogenous ligand on hema- 
topoietic cells (but not specialized epithelial cells) for their 
development (26,  27,  31). 
New evidence for the extrathymic origin of at least some 
NK1 + T  cells is presented by Sato et al. in this issue (22). 
In particular, these authors show that NK1 + T  cells (and 
other TCR  i~t cells) develop selectively in the liver and spleen 
of thymectomized irradiated F1 mice reconstituted with pa- 
rental or syngeneic bone marrow cells. In control (euthymic) 
irradiated mice, both NK1 + T  and conventional (TCR  hiSh) 
T  cells develop  in these organs; however,  the development 
of normal T  cells is delayed relative to NK1 + T  cells. The 
bone marrow precursors  of NK1 + T  cells in this adoptive 
transfer system express Thy-1 but not the TCR-CD3 com- 
plex. The findings of Sato et al. (22) are reminiscent of ear- 
lier reports in which TCR-c~/3 + cells were shown to be 
generated in vitro from bone marrow precursors (32-34); how- 
ever,  a very recent  study indicates that most TCR-a/3 + 
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1 + TCK-a/fl-  precursors are in fact NKI.1-  (35). 
If NK1 + T ceils do indeed arise extrathymically, it should 
in theory be possible to demonstrate activity of the recom- 
binase-activating genes (RAGs) (which are essential for TCR 
rearrangement)  in  NK1 +  T  precursor  cells in  the  corre- 
sponding tissues. In this regard,  RAG-1  and RAG-2 mes- 
senger KNA have been detected previously by PCR in liver 
mononuclear ceils (36); however, no RAG-1 transcripts could 
be detected in liver by Northern blot in a subsequent study 
(37). Interestingly, Sato et al. (22) find that RAG-1 transcripts 
are expressed at much higher levels among liver mononuclear 
cells of reconstituted radiation bone marrow chimeras than 
in normal mouse liver. These data are consistent with an in- 
creased  rate  of  extrathymic  TCK-a/fl  rearrangement  in 
NK1 + T  cell precursors in the chimeric animals. 
Ligand Specificity of NK1 + T  Cells 
As mentioned above, most NK1 + T  ceils express a TCK 
with a limited fl chain (V~8.2, Vfl7, or Vfl2) and virtually 
invariant a  chain (Va14-Jot281)  usage. It therefore seems likdy 
that the ligand(s) for this TCK will be highly restricted (or 
even monomorphic). Several experiments in vivo using gene- 
targeted "knockout" mice have provided dues as to the poten- 
tial ligands that control NK1 + T  ceil development. Thus, 
it is dear that NK1 + T  cells in thymus (27, 31, 38) or liver 
(26),  as well as the related Vot14 + peripheral T  cell subset 
(39),  fail  to  develop in fl2-microglobulin (fl2-m)-deficient 
mice, suggesting that a flzm-assodated (i.e., MHC class I or 
rdated) molecule is a component of the ligand of the NK1 + 
T cell receptor. Further insight into the nature of this puta- 
tive ligand comes from recent analysis of mice deficient for 
the peptide transporter-associated protein 1 (TAP-l). In these 
mice, which lack conventional MHC class I molecules (H-2K, 
D  and L),  Vc~14 +  T  cells  (and hence,  presumably,  most 
NK1 + T  cells) develop normally (39).  Taken together, the 
data with mutant mice suggest that NK1 + T  cells recog- 
nize a flzm-assodated molecule that does not require pep- 
tides transported by TAP-1 for its assembly and surface ex- 
pression. Interestingly, there are at least two wdl-characterized 
molecules that fulfill these criteria: the thymus leukemia an- 
tigen (40) and CD1 (41). In this context, Taniguchi and co- 
workers  have  identified  a  wild  mouse  strain  in  which 
Vcd4 + T cells do not devdop. In F2 backcross analysis,  this 
defect segregates as a single recessive gene that is unlinked 
to the MHC  (39).  If, indeed, the absence of Val4 + ceils 
in these wild mice reflects a defect in the ligand responsible 
for  NK1 +  T  cell  development,  then  it  follows  that  the 
thymus leukemia antigen (which is dosdy linked to the MHC) 
cannot be the relevant ligand. 
The case favoring CD1 as a potential ligand for NK1 + T 
cdls has been greatly strengthened by very recent analysis 
of the specificity of NK1 + T  hybridomas. Thus, Bendelac 
et al. (42) demonstrated that several hybridomas bearing the 
invariant Vc~14-Jc~281 rearrangement could be stimulated to 
produce  lymphokines  in  vitro  after  exposure  to  CD1- 
expressing thymocytes or fibroblasts infected with a vaccinia 
construct containing the mouse CD1 gene. Furthermore, this 
stimulation could be inhibited by mAbs to either the TCK 
or to CD1. Weaker reactivity of freshly isolated normal thymic 
NK1 § T  cells to CDl-expressing fibroblasts could also be 
demonstrated. These data provide the first convincing evi- 
dence that CD1 is a component of the physiological ligand 
recognized by the TCK on NK1 + T ceils. It will be of great 
interest to determine whether CD1 can associate with pep- 
tides or other nonpeptidic moieties to stimulate NK1 + T 
cells.  In this respect, it is known that some human TCK- 
odfl + clones can recognize mycolic acid (a mycobacterial ceil 
waU product) in association with CDlb  (43). 
In considering the possible ligands recognized by NK1 + 
T cells, it should be emphasized that the potential contribu- 
tion of the NKI.1 molecule itself to ligand specificity cannot 
be discounted. Indeed, NKI.1 is a member of the NKK-Pl 
family of C-type (calcium-dependent) lectins,  and there is 
evidence that at least some members of this family may in- 
teract with complex oligosaccharides present on the surface 
of certain "NK-susceptible" target cells (6). In conventional 
NK cdls,  this interaction apparently leads to activation of 
the cytolytic program (6,  7).  Furthermore, both NK cells 
(2) and activated NK1 + T cells (44) are capable of redirected 
lysis of Fc receptor-bearing target ceils in the presence of anti- 
NKI.1 antibodies. Collectivdy, these data raise the possibility 
that  the  NKI.1  molecule on  NK1 +  T  cells  (or  another 
NKR-Pl  family  member)  may  confer  specificity  for  an 
oligosaccharide ligand and/or a carbohydrate component of 
a complex ligand (perhaps involving CD1) that is corecog- 
nized by the ot/fl TCR.  In the latter case, NKI.1 could be 
considered as a type of coreceptor molecule that modifies the 
avidity of TCR-ligand interactions on NK1 + T  ceils. This 
speculative model (Fig.  1) is further supported by the fact 
that the cytoplasmic domains of NKR-P1  family members 
share a motif (Cys-X-Cys-Pro)  that has been shown to be 
involved in the association of CD4 and CD8 coreceptors with 
the tyrosine kinase p561ck (2). However, no direct evidence 
for a molecular association between p561ck and NKI.1  has 
been reported. 
Function of NK1 + T  Cells 
Because of the lack of precise knowledge of their ligand 
specificity, the function of NK1 + T  ceils under physiolog- 
ical conditions has been difficult to address.  However,  the 
functional potential of NK1 + T  cells has been investigated 
in vivo and in vitro by triggering their TCK-CD3 complex 
with mAbs. Such studies have shown a remarkable ability 
of NK1 + T  cells to produce large amounts of cytokines and, 
in particular, IL-4. Indeed, it is likely that virtually all the 
IL-4 produced in vitro by anti-CD3-stimulated thymocytes 
can be accounted for by the NKI.1 + T  subset (45, 46), and 
similar conclusions have been reached for splenic T ceUs from 
normal mice injected with anti-CD3 mAbs (47). As pointed 
out by others (47), this property of NK1 + T ceils may have 
important implications for the development of conventional 
CD4 + TCR-c~/fl + ceils of the Th2 cytokine profile, since, 
in many systems, Th2 cells arise preferentially (or exclusively) 
635  MacDonald Figure 1.  Specuhtive  coreceptor  model for CD1 ligand recognition by 
NK1 + T cells. In this model, the highly conserved  TCK-ot/B on NK1 + 
T cells  reacts  with the nonpolymorphic  CD1 molecule. At the same  time, 
the extracellular C-type  lectin  domain of  NKI.1 interacts with a carbohy- 
drate moiety on CD1 to stabilize TCR binding. By analogy with CD4 
and CD8 on conventional  T cells, NKI.1 could thus signal as a coreceptor 
via its putative cytoplasmic  association  with the tyrosine kinase p561ck. 
It is not known whether the peptide-binding groove  of CD1 is occupied, 
and the putative carbohydrate moiety could be of either endogenous or 
exogenous  origin. Note that NKI.1 is a homodimer and hence  could the- 
oretically cross-link TCR-CD1 complexes. 
under conditions of stimulation where IL-4 is already present. 
Indeed, it has been shown recently that CD4 + cells with a 
CD62L  l~  phenotype (a population that includes NK1 + T 
cells) are required to direct the in vitro differentiation of Th2 
cells from naive CD4 + precursors  (48). 
Unlike conventional NK cells,  NK1 + T  cells appear not 
to lyse NK-sensitive target calls such as YAC-1 when freshly 
isolated ex vivo; however, they are capable of redirected lysis 
of Fc receptor-bearing  target  cells in the presence of anti- 
bodies to the TCR-CD3 complex (11). Furthermore,  NK1 + 
T cells (like NK cells) can be induced to kill tumor ceils after 
exposure to cytokines such as IL-2 and IL-4 in vitro (44, 49, 
50) or IL-12 in vivo (30). Interestingly, even freshly isolated 
thymic  NK1 +  T  cells  are  able  to  lyse  normal  cortical 
(CD4 +8 +)  thymocytes,  apparently  via  the  Pas-mediated 
pathway (51). Since cortical thymocytes express the putative 
NK1 +  T  cell ligand  CD1  (52),  it  is possible that  NK1 + 
T  cells may play a role in thymic selection or homeostasis. 
Are NKI + T  Cells  "Suppressor" Cells? 
No  discussion  of  NK1 +  T  cells  would  be  complete 
without reforence to their possible relationship to suppressor 
cells. Indeed, the invariant Vot14-Jot281  rearrangement  that 
is now known  to be characteristic  of most NK1 + T  ceils 
was first identified as a conserved rearrangement  in a panel 
of KLH-specific suppressor cell hybridomas (53), and other 
suppressor T  cell hybridomas  specific  for antigens  such as 
DNP use the identical ot chain (54). Although the actual mech- 
anism  of suppression mediated by such hybridomas is  still 
not well defined, it is tempting to speculate that  NK1 + T 
cells may in general be involved in negative regulatory func- 
tions, perhaps facilitated by their cytolytic activity and potential 
to  secrete large amounts  of inhibitory  cytokines. 
A  more  physiological  regulatory  function  of NK1 +  T 
cells relates to the supression of  hemopoiesis.  It has been known 
for many years that irradiated  F1 mice frequently reject pa- 
rental bone marrow grafts. The phenomenon, known as hy- 
brid resistance,  is genetically complex and involves the par- 
ticipation  of NKI.1 +  effector cells  (55).  Whereas  it  was 
initially assumed that these effector cells are conventional NK 
cells,  several  studies clearly implicate  NK1 + T  cells  in  hy- 
brid resistance (10, 56). This issue is currently controversial, 
and it is possible that  both NK and NK1 + T  cells may be 
involved in  the  suppression  of hemopoiesis  (55). 
NKI + T  Cells Expressing  TCR-'y/$ 
This commentary has focused on the well-established  subset 
of NK1 + T  cells that expresses TCR-c,//~. However, in this 
issue of the journal, Arase et al. (57) describe a novel popula- 
tion  of TCR-3,//~ +  NK1 +  T  cells  that  is present  in  very 
low frequency in normal thymus. Interestingly,  TCR~//~ + 
NK1 + T  cells are increased dramatically in the  thymus of 
CD3-~'-deficient  mice,  where,  in  contrast,  mature  TCR- 
o~//~ + cells (indnding  the NK1 + T  subset) fail  to develop. 
By analogy to conventional TCR-3d6 + cells present in the 
gut  epithelium  (58),  it  is  likely  that  thymic  TCR-'y//~ + 
NK1 + T  cells are able to develop in CD3-~'-deficient mice 
because the CD3~'-chain in their TCR complex can be sub- 
stituted by the homologous FceRI ~/chain, which normally 
assodates with CD16 to form the high atfinity Fc receptor 
(59, 60). In any event, it will be of considerable interest  to 
further characterize this novel NKI.1 + TCR-3'//5 + subset in 
terms of its origin and function. Given the paucity of infor- 
mation concerning the physiological  ligand recognized by con- 
ventional TCR-3,//~ cells, it will be particularly challenging 
to address the specificity of the NK1 §  TCR-34/~ receptor. 
As a first approach, it will obviously be informative to inves- 
tigate whether V gene usage is biased in these cells, as is the 
case for the  TCR-ot/B + NK1 + T  subset. 
Concluding  Remarks 
NK1 + T  calls represent a fascinating subset of TCR-ot/3 
(and apparently TCR-3,//~) ceils with poorly defined ligand 
specificity.  As outlined here, it appears likely that NK1 + T 
cells can develop independently in several extrathymic tissues 
(notably bone marrow and liver) as well as in the thymus. 
Because of their ability to secrete large amounts oflL-4 upon 
TCR  engagement,  NK1 + T  cells may play a pivotal role 
in Thl/Th2  lineage  commitment  of conventional  CD4 + 
TCR.-a/•  +  cells.  Furthermore,  the potential  of NK1 + T 
cells to mediate target cell lysis under certain conditions may 
allow them to carry out other regulatory functions, such as 
the suppression of immune responses or of hemopoiesis. U1- 
timatdy, NK1 + T  cells may turn out to be bona fide regula- 
tory T cells that can even be discussed openly in public (61). 
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